When Asi Naim, a severely autistic Israeli boy, started smacking his head against the wall and hurting himself in other ways, his parents tried every kind of psychiatric drug to calm him. Nothing worked. Then Asi entered a cannabis-based research program at Jerusalem’s Shaarei Zedek hospital.
The same medication has helped many of the 60 autistic children enrolled in neuro-pediatrian Adi Aran’s program. The end goal: approval by the U.S. Federal Drug Administration as an experimental treatment.